Latest Prostate Cancer News
After 2 years, continence, potency, and freedom from recurrence were achieved in almost half of men who had extended pelvic lymph node dissection.
In studies, subsequent use of chemotherapy and concomitant use of abiraterone or enzalutamide did not raise any new safety concerns.
A year after the federal task force came out against routine PSA screening, diagnoses of low-risk PCa decreased by 38% and continued to fall.
TMPRSS2-ERG in peripheral blood mononuclear cells is linked to greater progression risk in men with metastatic CRPC treated with docetaxel.
Biochemical failure rates, however, appear to be better with radiation, single-institution study finds.
Compared with combination treatment, radiation therapy alone was linked with 64% and 83% lower odds of early death and death from cardiac causes among patients with co-existing illnesses.
Findings among veterans flagged for delayed diagnosis of prostate, colorectal cancer.
Rates of adverse pathology varied from 24% for men with more than 2 positive biopsy cores to 45% in men reclassified by Gleason score.
Over 3 years after radical surgery, men who delayed surgery and those who had immediate surgery had similar rates of biochemical recurrence.
This approach is, or should be, the standard of care for locally advanced PCa, some researchers say.
Findings could have implications for active surveillance criteria for African Americans.
Study finds a 66% increased risk of dying from the malignancy in prostate cancer patients with the highest stress levels.
Reduction in prostate-specific antigen level in some patients with biochemical recurrence.
Small study demonstrates the promise of PET-CT using a radiotracer that targets the prostate-specific membrane antigen.
No residual tumor was found in 5.4% of men who received androgen deprivation therapy prior to radical surgery for high-risk prostate cancer.
Prostate Cancer Videos
Sign up for free e-Newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)